B Braun Medical Inc Company Profile

What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?

B BRAUN MEDICAL INC has eleven approved drugs.

There are two US patents protecting B BRAUN MEDICAL INC drugs.

There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-eight supplementary protection certificates in fifteen countries.

Summary for B Braun Medical Inc

International Patents:	27
US Patents:	2
Tradenames:	11
Ingredients:	10
NDAs:	11
Drug Master File Entries:	21

Drugs and US Patents for B Braun Medical Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical Inc	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-002	Apr 30, 2015		RX	No	No
B Braun Medical Inc	MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER	magnesium sulfate	INJECTABLE;INJECTION	207966-001	Oct 27, 2020	AP	RX	No	No
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-002	Feb 27, 2024	AP	RX	No	No
B Braun Medical Inc	ACETAMINOPHEN	acetaminophen	SOLUTION;INTRAVENOUS	204957-001	Feb 18, 2021		RX	Yes	Yes
B Braun Medical Inc	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-003	Feb 27, 2024	AP	RX	No	No
B Braun Medical Inc	CLOROTEKAL	chloroprocaine hydrochloride	SOLUTION;INTRATHECAL	208791-001	Sep 26, 2017		DISCN	Yes	No	8,969,412		Y
B Braun Medical Inc	ACETAMINOPHEN	acetaminophen	SOLUTION;INTRAVENOUS	204957-002	Feb 18, 2021		RX	Yes	Yes

International Patents for B Braun Medical Inc Drugs

Country	Patent Number	Estimated Expiration
Poland	1931304
Ukraine	115078
Italy	MI20122120
South Korea	20150085131
Croatia	P20131221
New Zealand	709631
Argentina	099443

Supplementary Protection Certificates for B Braun Medical Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0521471	SPC/GB03/033	United Kingdom		PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
2365988	LUC00061	Luxembourg		PRODUCT NAME: PATIROMER SORBITEX CALCIUM ET TOUS LES SELS ET DERIVES DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2957286	2018/046	Ireland		PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719
2603514	2019014	Norway		PRODUCT NAME: A COMBINATION OF VABORBACTAM, AND/OR A SALT AND/OR HYDRATE THEREOF, AND MEROPENEM, AND/OR A SALT AND/OR HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE; REG. NO/DATE: EU/1/18/1334/001 20181122
0984957	CR 2012 00035	Denmark		PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
0933372	PA2008006	Lithuania		PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
0933372	13/2008	Austria		PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• B Braun
• B Braun Medical Inc